Evaluation of the Effect of Combination Therapy on Treatment of COVID-19: A Cohort Study

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Ghazale Amir Hosein; GHAZVINI ALI; GHANEI MOSTAFA; VAHEDI ENSIEH; Omidian Shideh; MOZAFARI ABOLFAZL; REZAPOUR MOHAMMAD; rastgoo Nafiseh; Movaseghi Fatemeh; MANSOURI FATEMEH; ZOHAL MOHAMMAD ALI; Gheraati Maryam; SAADAT SEYED HASSAN; GOODARZI HASSAN; GHOLAMI FESHARAKI MOHAMMAD; Dehghan Banadkooki Amir Mohammad; Saloo Shahrzad; Salou Hesamodin

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2021 | Volume:23 | Issue:6 Page(s): 0-0

Download Full-Text

View:

288

Download:

Cites:

Information Journal Paper

Title

Evaluation of the Effect of Combination Therapy on Treatment of COVID-19: A Cohort Study

Author(s)

Keywords

Anti-inflammatory drugs

Antiviral drugs

Combination therapy

Corticosteroid

COVID-19

Immunomodulators drugs

Abstract

Background: COVID-19 is a new disease for which a definitive treatment has not yet been proposed. Objectives: The present study aimed to investigate the effect of Combination therapy on the treatment of COVID-19 due to the importance of finding an appropriate treatment for this epidemic disease. Methods: This two-center cohort study included 175 confirmed COVID-19 inpatients at two medical centers designated for the treatment of COVID-19 patients in Qom and Qazvin, Iran. In this study, four different groups of drug regimens were studied which included G1 (azithromycin, prednisolone, and naproxen), G2 (lopinavir/ritonavir, azithromycin, naproxen, and prednisolone), G3 (hydroxychloroquine, azithromycin, naproxen, and prednisolone), and G4 (levofloxacin, vancomycin, hydroxychloroquine, and oseltamivir). It should be noted that G1, G2, G3, and G4 treatment regimens were used on 48, 39, 30, and 77 patients, respectively. Results: The study participants included 175 confirmed COVID-19 patients with mean± SD age of 58. 9 ± 15. 1 years, out of whom 80 (46%) patients were male and the rest were females. The results indicated that the hospital stay period was significantly shorter in the G1 compared to other groups (G1: 5. 9± 2. 4, G2: 8. 1± 4. 2, G3: 6. 3± 1. 7, and G4: 6. 4± 2. 9; [P-value=0. 008]). It should be noted that pulse rate, oxygen saturation, hemoglobin, and platelet count (PLT) changed significantly during the study in four treatment groups; however, a significant change in temperature, creatinine, and white blood cell (WBC) was observed only in G3, G4, and G1 groups, respectively. The number of ICU admissions and deaths were not statistically significant among the patients who received the four treatment regimens (P=0. 785). Based on the results, the history of ischemic heart disease, baseline oxygen saturation, WBC, neutrophil, lymphocyte count, and C-reactive protein (CRP) are the risk factors for the prolonged hospital stay in COVID-19 patients. Conclusion: The obtained results in this study indicated that the combination of azithromycin, prednisolone, and naproxen is the most effective regimen for the treatment of COVID-19, compared to three other combination treatment regimens.

Cites

No record.

References

Cite

APA: Copy

Ghazale, Amir Hosein, GHAZVINI, ALI, GHANEI, MOSTAFA, VAHEDI, ENSIEH, Omidian, Shideh, MOZAFARI, ABOLFAZL, REZAPOUR, MOHAMMAD, rastgoo, Nafiseh, Movaseghi, Fatemeh, MANSOURI, FATEMEH, ZOHAL, MOHAMMAD ALI, Gheraati, Maryam, SAADAT, SEYED HASSAN, GOODARZI, HASSAN, GHOLAMI FESHARAKI, MOHAMMAD, Dehghan Banadkooki, Amir Mohammad, Saloo, Shahrzad, & Salou, Hesamodin. (2021). Evaluation of the Effect of Combination Therapy on Treatment of COVID-19: A Cohort Study. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 23(6), 0-0. SID. https://sid.ir/paper/704485/en

Vancouver: Copy

Ghazale Amir Hosein, GHAZVINI ALI, GHANEI MOSTAFA, VAHEDI ENSIEH, Omidian Shideh, MOZAFARI ABOLFAZL, REZAPOUR MOHAMMAD, rastgoo Nafiseh, Movaseghi Fatemeh, MANSOURI FATEMEH, ZOHAL MOHAMMAD ALI, Gheraati Maryam, SAADAT SEYED HASSAN, GOODARZI HASSAN, GHOLAMI FESHARAKI MOHAMMAD, Dehghan Banadkooki Amir Mohammad, Saloo Shahrzad, Salou Hesamodin. Evaluation of the Effect of Combination Therapy on Treatment of COVID-19: A Cohort Study. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2021;23(6):0-0. Available from: https://sid.ir/paper/704485/en

IEEE: Copy

Amir Hosein Ghazale, ALI GHAZVINI, MOSTAFA GHANEI, ENSIEH VAHEDI, Shideh Omidian, ABOLFAZL MOZAFARI, MOHAMMAD REZAPOUR, Nafiseh rastgoo, Fatemeh Movaseghi, FATEMEH MANSOURI, MOHAMMAD ALI ZOHAL, Maryam Gheraati, SEYED HASSAN SAADAT, HASSAN GOODARZI, MOHAMMAD GHOLAMI FESHARAKI, Amir Mohammad Dehghan Banadkooki, Shahrzad Saloo, and Hesamodin Salou, “Evaluation of the Effect of Combination Therapy on Treatment of COVID-19: A Cohort Study,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 23, no. 6, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/704485/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops